 However, the dosage required to maintain antiarrhythmic effects is still not clear.In short-term and more prolonged studies, acecainide 1.5 to 2.0 g as a single dose or as three or four divided doses a day appears to be satisfactory in controlling PVCs.In patients who are refractory to other antiarrhythmic agents, the doses required appear to be greater.